Clinical trial
Clinical Efficacy of Bevacizumab Combined With Navigated Laser in Patients With Clinically Significant Macula Edema
NCT02032238 is registered in ClinicalTrials.gov with OD-OS GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Efficacy of Bevacizumab Combined With Navigated Laser in Patients With Clinically Significant Macula Edema
- Lead sponsor
- OD-OS GmbH
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- March 31, 2013
- Completion date
- June 30, 2015
- Enrollment
- 12 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
clinically significant macular edema